JOURNAL ARTICLE

Blood neutrophil-to-lymphocyte ratio is associated with prognosis in advanced gastrointestinal stromal tumors (GIST) treated with imatinib

Keywords:
Medicine GiST Internal medicine Imatinib Gastroenterology Proportional hazards model Imatinib mesylate Neutrophil to lymphocyte ratio Stromal tumor Oncology Log-rank test Lymphocyte Stromal cell

Metrics

0
Cited By
0.00
FWCI (Field Weighted Citation Impact)
0
Refs
0.25
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Topics

Gastrointestinal Tumor Research and Treatment
Health Sciences →  Medicine →  Gastroenterology
Inflammatory Biomarkers in Disease Prognosis
Health Sciences →  Medicine →  Oncology
Metastasis and carcinoma case studies
Health Sciences →  Medicine →  Pulmonary and Respiratory Medicine

Related Documents

© 2026 ScienceGate Book Chapters — All rights reserved.